Vanda Pharmaceuticals Inc (VNDA)

08:57 AM

Vanda Pharmaceuticals' (VNDA) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

08:57 AM

Jan 20, 2025

Vanda Pharmaceuticals (NASDAQ:VNDA) Now Covered by Analysts at StockNews.com - MarketBeat

Jan 20, 2025

Jan 18, 2025

Vanda asserts FDA review of tradipitant was flawed - MSN

Jan 18, 2025

Jan 17, 2025

Insomnia Market Overall Study Report 2025-2032 | Vanda - openPR

Jan 17, 2025

Jan 16, 2025

Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda, Neurogastrx, Inc, PTC Thera - The Globe and Mail

Jan 16, 2025

Jan 16, 2025

FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate - Yahoo Finance

Jan 16, 2025

Jan 15, 2025

Pugilistic Vanda Collects Another NOOH As US FDA Defends Tradipitant Turndown - News & Insights

Jan 15, 2025

Jan 15, 2025

DC Circuit Skeptical of FDA Rejection of Vanda’s Jet Lag Drug - Bloomberg Law

Jan 15, 2025

Jan 13, 2025

High Court Rejects Vanda Suit Over Medicaid Drug Definition - Bloomberg Law

Jan 13, 2025

Jan 08, 2025

Vanda Pharmaceuticals Highlights Issues in Gastroparesis Treatment Application Review in Letter to FDA Commissioner - Marketscreener.com

Jan 08, 2025

Jan 08, 2025

Vanda Pharmaceuticals Challenges FDA Over Gastroparesis Drug Rejection in Open Letter - StockTitan

Jan 08, 2025

Jan 06, 2025

Is it a Good Idea to Invest in Vanda Pharmaceuticals Stock Now? - Yahoo Finance

Jan 06, 2025

Jan 04, 2025

StockNews.com Initiates Coverage on Vanda Pharmaceuticals (NASDAQ:VNDA) - MarketBeat

Jan 04, 2025

Dec 27, 2024

Vanda Pharmaceuticals (NASDAQ:VNDA) Earns Hold Rating from Analysts at StockNews.com - MarketBeat

Dec 27, 2024

Dec 24, 2024

3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying - Yahoo Finance

Dec 24, 2024

Dec 23, 2024

Vanda’s VGT-1849A gets orphan designation for polycythemia vera - BioWorld Online

Dec 23, 2024

Dec 23, 2024

HC Wainwright Reiterates Buy Rating for Vanda Pharmaceuticals (NASDAQ:VNDA) - MarketBeat

Dec 23, 2024

Dec 20, 2024

Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity - Seeking Alpha

Dec 20, 2024

Dec 20, 2024

Vanda Pharmaceuticals Gets FDA Orphan-Drug Designation for Cancer Treatment - MarketWatch

Dec 20, 2024

Dec 20, 2024

Exploring Three High Growth Tech Stocks In The United States - Simply Wall St

Dec 20, 2024

Dec 20, 2024

Vanda Pharmaceuticals Secures FDA Orphan Drug Status for Novel Blood Cancer Treatment VGT-1849A - StockTitan

Dec 20, 2024

Dec 19, 2024

Diabetic Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharmaceuticals, Ironwood Pharma, Takeda - The Globe and Mail

Dec 19, 2024

Dec 18, 2024

FDA's Gastro Drug Fast-Track Denial Survives DC Circ. - Law360

Dec 18, 2024

Dec 18, 2024

US Penny Stocks To Watch In December 2024 - Simply Wall St

Dec 18, 2024

Dec 17, 2024

DC Circuit Affirms FDA's Fast-Track Denial of Vanda Stomach Drug - Bloomberg Law

Dec 17, 2024

Dec 16, 2024

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc. - Marketscreener.com

Dec 16, 2024

Dec 14, 2024

Vanda Pharmaceuticals' SWOT analysis: stock poised for growth amid challenges - Investing.com

Dec 14, 2024

Dec 14, 2024

Vanda Pharmaceuticals' SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 11, 2024

Vanda Pharmaceuticals (NASDAQ:VNDA) Now Covered by StockNews.com - MarketBeat

Dec 11, 2024

Dec 10, 2024

Vanda Expands Efforts to Pull Two Hetlioz Copies From US Shelves - Bloomberg Law

Dec 10, 2024

Dec 01, 2024

Vanda Pharmaceuticals (STU:VM4) EV-to-Revenue : -0.37 (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024

Nov 28, 2024

Massachusetts Financial Services Co. MA Purchases New Stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) - MarketBeat

Nov 28, 2024

Nov 26, 2024

Gastroparesis Drugs Market to Grow by USD 1.42 Billion (2024-2028), Diabetes Burden Boosts Growth, AI Impact on Market TrendsTechnavio - The Malaysian Reserve

Nov 26, 2024

Nov 19, 2024

Long Term Trading Analysis for (VNDA) - Stock Traders Daily

Nov 19, 2024

Nov 18, 2024

Vanda Pharmaceuticals director sells $25,863 in stock By Investing.com - Investing.com Canada

Nov 18, 2024

Nov 18, 2024

Vanda Pharmaceuticals director sells $25,863 in stock - Investing.com India

Nov 18, 2024

Nov 14, 2024

New Strong Buy Stocks For November 14th - Barchart

Nov 14, 2024

Nov 12, 2024

Vanda Pharmaceuticals to Present at Major Stifel, Jefferies Healthcare Conferences | VNDA Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

BML Capital Management LLC Sells 169,780 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) - MarketBeat

Nov 12, 2024